SNOA Stock Analysis: Buy, Sell, or Hold?
SNOA - Sonoma Pharmaceuticals, Inc. Common Stock
$1.10
0.01 (0.92%)
▲
5d:
-9.09%
30d:
-6.78%
90d:
-55.1%
HOLD
LOW Confidence
Analysis Updated: Jun 11, 2026 12:00 AM ET
Earnings: Jun 16, 2026
3d
Get Alerted When SNOA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNOA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SNOA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SNOA is currently trading at $1.10, which is considered slightly low relative to its 30-day fair value range of $1.07 to $1.19.
Technical Outlook: Technically, SNOA is in a strong downtrend. Immediate support is located at $1.05, while resistance sits at $1.29.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+990.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNOA is in a strong downtrend. Immediate support is located at $1.05, while resistance sits at $1.29.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+990.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.07 -
$1.19
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 990.9% below Wall St target ($12.00)
- CAUTION: Recommendation downgraded due to -9.1% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.07 -
$1.19
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.05
Resistance Level
$1.29
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.96
Wall Street Target
$12.00
(+990.9%)
Revenue Growth (YoY)
22.0%
Profit Margin
-19.0%
Share & Embed Analysis
Last updated: June 12, 2026 8:20 AM ET
Data refreshes hourly during market hours. Next update: 9:20 AM
Data refreshes hourly during market hours. Next update: 9:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNOA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$193 | 62 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 58 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$66 | 66 BUY |
